CHEK1 and neoplasm: However, when combined with the increase in miR-320c and oxaliplatin treatment in TNBC cell lines, Chk1 could not be sufficiently activated because of the miR-320c effect, and unrepaired DNA damages accumulated, resulting in suppressed tumor progression.